Fiveable

🤒Intro to Epidemiology Unit 16 Review

QR code for Intro to Epidemiology practice questions

16.1 Global burden of disease

16.1 Global burden of disease

Written by the Fiveable Content Team • Last updated August 2025
Written by the Fiveable Content Team • Last updated August 2025
🤒Intro to Epidemiology
Unit & Topic Study Guides

Global Burden of Disease

The global burden of disease (GBD) is a framework for measuring how much health loss different diseases and injuries cause across the world. It matters in epidemiology because it moves beyond simple death counts to capture the full picture: who's dying, who's living with disability, and where the biggest gaps in health exist. This unit covers the leading causes of morbidity and mortality, how DALYs quantify disease impact, how the epidemiologic transition reshapes health patterns over time, and how social determinants drive disparities.

Global morbidity and mortality causes

Cardiovascular diseases (heart attacks, strokes, and other circulatory conditions) are the leading cause of death globally, responsible for roughly 17.9 million deaths per year according to WHO estimates. Cancer ranks second, with lung, breast, and colorectal cancers among the most common types. Chronic respiratory diseases like COPD and asthma are another major source of both death and long-term disability.

Dementia, particularly Alzheimer's disease, is a growing contributor to disability as populations age, progressively impairing cognitive function and quality of life.

Regional patterns differ sharply:

  • High-income countries bear a heavier burden from non-communicable diseases (NCDs) like diabetes, hypertension, and heart disease. These reflect aging populations and lifestyle-related risk factors.
  • Low-income countries still struggle disproportionately with infectious diseases (malaria, tuberculosis, HIV/AIDS) and maternal and child health issues like malnutrition and complications during childbirth.

Age-specific patterns also matter:

  • Children are most vulnerable to lower respiratory infections and diarrheal diseases, especially in resource-poor settings.
  • Adults face higher risk from ischemic heart disease and stroke, particularly after middle age.

Two emerging categories deserve attention. Mental health disorders like depression and anxiety are increasingly recognized as major contributors to disability worldwide, even though they often don't show up in mortality statistics. Substance use disorders, including the opioid crisis, carry far-reaching health and societal impacts that cut across income levels.

Global morbidity and mortality causes, Most Common Causes of Death | Lifespan Development

Disability-adjusted life years concept

DALYs give you a single number that captures the total health loss from a disease by combining both death and disability. One DALY equals one lost year of full health.

DALYs have two components:

  • Years of Life Lost (YLL): the number of years lost due to premature death, calculated against a standard life expectancy.
  • Years Lived with Disability (YLD): the number of years spent living in less-than-full health, weighted by the severity of the condition.

The formula is straightforward:

DALY=YLL+YLDDALY = YLL + YLD

For example, if a disease kills someone 20 years before their expected lifespan, that's 20 YLL. If another person lives 10 years with a condition weighted at 0.5 severity, that's 5 YLD. Together, those two cases contribute 25 DALYs.

Why DALYs matter beyond simple death counts:

  • They let you compare the impact of very different conditions on the same scale. A disease that kills quickly and one that causes decades of disability can be weighed against each other.
  • They enable comparisons across regions and populations, revealing where health loss is concentrated.
  • They guide resource allocation by showing policymakers which diseases cause the most total burden, not just the most deaths.
  • They help track population health trends over time, so you can see whether interventions are working.
Global morbidity and mortality causes, Changing disease burdens and risks of pandemics (GMT 3) — European Environment Agency

Impact of epidemiologic transition

The epidemiologic transition describes how the dominant causes of death in a population shift over time as societies develop. Understanding which stage a country is in helps explain its disease burden and predict future health needs.

The classic model has four stages:

  1. Age of Pestilence and Famine: High mortality from infectious diseases, famine, and poor sanitation. Life expectancy is low (often under 40 years). This characterized most of human history.
  2. Age of Receding Pandemics: Improved sanitation, nutrition, and early public health measures cause epidemic diseases to decline. Mortality drops and life expectancy begins to rise.
  3. Age of Degenerative and Man-Made Diseases: As people live longer, chronic conditions like heart disease, cancer, and stroke become the leading killers. Lifestyle factors (diet, smoking, sedentary behavior) play a larger role.
  4. Age of Delayed Degenerative Diseases: Medical advances and better chronic disease management push the onset of degenerative diseases to later ages. Life expectancy continues to increase.

Several factors drive this transition, and they don't happen at the same pace everywhere:

  • Socioeconomic development improves living conditions, nutrition, and access to healthcare.
  • Medical advancements enhance prevention (vaccines) and treatment (antibiotics, surgical techniques).
  • Public health interventions reduce exposure to environmental hazards and infectious agents.

The transition's effects on the global burden of disease are significant. The leading causes of death shift from infectious to non-communicable diseases. Life expectancy increases, which changes the age structure of the population. An older population, in turn, demands different healthcare resources: more chronic disease management, long-term care, and geriatric services rather than acute infectious disease treatment.

Many low- and middle-income countries now face a double burden, dealing with persistent infectious diseases while also seeing rising rates of NCDs. This makes resource allocation especially challenging.

Social determinants in disease burden

Social determinants of health are the conditions in which people are born, grow, live, work, and age. They operate upstream of individual health behaviors and have a powerful influence on who gets sick and who stays healthy.

Key determinants include:

  • Education: Higher education levels are linked to better health literacy, healthier lifestyle choices, and higher income.
  • Income and wealth: These determine access to nutritious food, safe housing, and quality healthcare. Poverty is one of the strongest predictors of poor health outcomes globally.
  • Employment: Job security affects stress levels, access to health insurance, and exposure to occupational hazards.
  • Housing: Overcrowded or substandard housing increases exposure to environmental risks like mold, pollution, and infectious disease transmission.
  • Access to healthcare: Without affordable, geographically accessible care, preventive services and early treatment are out of reach for many populations.

These determinants create visible health disparities:

  • Health inequities persist both between countries (e.g., life expectancy in Japan vs. Sierra Leone) and within countries (e.g., wealthier vs. poorer neighborhoods in the same city).
  • People of lower socioeconomic status face greater exposure to risk factors like air pollution, unsafe water, and food insecurity.
  • Cultural and economic factors shape health-seeking behaviors, influencing when and whether people access care.

Addressing social determinants requires working beyond the healthcare system alone. Intersectoral collaboration brings together stakeholders from education, housing, labor, and health sectors. Policy interventions that target root causes, such as poverty reduction programs or expanding access to education, tend to have broader and more lasting effects than treating diseases one at a time. Community-based approaches that empower local populations to identify and address their own health challenges are also a key part of the strategy.